By NewsDesk @bactiman63 Boston-based biopharmaceutical company, Paratek Pharmaceuticals announced the novel, once-daily oral and intravenous antibiotic NUZYRA® (omadacycline) has recently been added...

This week, the U.S. Department of Health and Human Services (HHS) issued the first Project BioShield contract to fund the advanced development needed to support the expanded use of an existing antibiotic...